Pasar al contenido principal

HETEROGENEIDAD DYNAMICA DE MICROGLIA Y MECANISMOS REGULADORES DE PLASTICIDAD FENOTIPICA

RTI2018-102260-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

KAT3-dependent acetylation of cell type-specific genes maintains neuronal identity in the adult mouse brain

  • Lipinski, Michal
  • Muñoz-Viana, Rafael
  • Blanco, Beatriz del
  • Marquez-Galera, Angel
  • Medrano-Relinque, Juan
  • Caramés, José M.
  • Szczepankiewicz, Andrzej A.
  • Fernandez-Albert, Jordi
  • Navarrón, Carmen M.
  • Olivares, Román
  • Wilczyński, Grzegorz Marek
  • Canals, Santiago
  • López-Atalaya, José P.
  • Barco, Ángel
The lysine acetyltransferases type 3 (KAT3) family members CBP and p300 are important transcriptional co-activators, but their specific functions in adult post-mitotic neurons remain unclear. Here, we show that the combined elimination of both proteins in forebrain excitatory neurons of adult mice resulted in a rapidly progressing neurological phenotype associated with severe ataxia, dendritic retraction and reduced electrical activity. At the molecular level, we observed the downregulation of neuronal genes, as well as decreased H3K27 acetylation and pro-neural transcription factor binding at the promoters and enhancers of canonical neuronal genes. The combined deletion of CBP and p300 in hippocampal neurons resulted in the rapid loss of neuronal molecular identity without de- or transdifferentiation. Restoring CBP expression or lysine acetylation rescued neuronal-specific transcription in cultured neurons. Together, these experiments show that KAT3 proteins maintain the excitatory neuron identity through the regulation of histone acetylation at cell type-specific promoter and enhancer regions., M.L. is recipient of a Santiago Grisolia fellowship given by the Generalitat Valenciana, J.M.C. is recipient of a fellowship from the Spanish Ministry of Education, Culture and Sport (MECD), J.F.-A. and C.M.N. are recipients of fellowships from the Spanish Ministry of Science and Innovation (MICINN). The ultrastructure research was supported by the Polish National Science Center Grant UMO-2014/15/N/NZ3/04468 and by the European Regional Development Fund POIG 01.01.02-00-008/08. J.P.L.-A. research is supported by Grants RYC-2015-18056 and RTI2018-102260-B-I00 from MICINN co-financed by ERDF. A.B. research is supported by Grants SAF2017-87928-R, PCIN-2015-192-C02-01, and SEV-2017-0723 from MICINN co-financed by ERDF, PROMETEO/2016/026 from the Generalitat Valenciana, and RGP0039/2017 from the Human Frontiers Science Program Organization (HFSPO). The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Astrocytes and neurons share region-specific transcriptional signatures that confer regional identity to neuronal reprogramming

  • Herrero-Navarro, Álvaro
  • Puche-Aroca, Lorenzo
  • Moreno-Juan, Verónica
  • Sempere-Ferràndez, Alejandro
  • Espinosa, Ana
  • Susín, Rafael
  • Torres-Masjoan, Laia
  • Leyva-Díaz, Eduardo
  • Karow, Marisa
  • Figueres-Oñate, Maria
  • López-Mascaraque, Laura
  • López-Atalaya, José P.
  • Berninger, Benedikt
  • López-Bendito, Guillermina
Neural cell diversity is essential to endow distinct brain regions with specific functions. During development, progenitors within these regions are characterized by specific gene expression programs, contributing to the generation of diversity in postmitotic neurons and astrocytes. While the region-specific molecular diversity of neurons and astrocytes is increasingly understood, whether these cells share region-specific programs remains unknown. Here, we show that in the neocortex and thalamus, neurons and astrocytes express shared region-specific transcriptional and epigenetic signatures. These signatures not only distinguish cells across these two brain regions but are also detected across substructures within regions, such as distinct thalamic nuclei, where clonal analysis reveals the existence of common nucleus-specific progenitors for neurons and astrocytes. Consistent with their shared molecular signature, regional specificity is maintained following astrocyte-to-neuron reprogramming. A detailed understanding of these regional-specific signatures may thus inform strategies for future cell-based brain repair., This work was supported by grants from the Spanish Ministry of Science, Innovation, and Universities cofinanced by ERDF (RYC-2015-18056 and RTI2018-102260-B-I00) to J.P.L.-A.; the Wellcome Trust (206410/Z/17/Z) and the German Research Foundation Collaborative Research Center 1080 (INST 161/875-2) to B.B.; and the European Research Council (ERC-2014-CoG-647012), PROMETEO/2017/149, and the Spanish Ministry of Science, Innovation, and Universities (PGC2018-096631-B-I00, BFU2015-64432-R, and Severo Ochoa Grant SEV-2017-0723) to G.L.-B. A.H.-N. held an FPI fellowship from the MINECO.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sublayer- and cell-type-specific neurodegenerative transcriptional trajectories in hippocampal sclerosis

  • Cid Ledesma, Elena
  • Marquez-Galera, Angel
  • Valero, Manuel
  • Gal, Beatriz
  • Medeiros, DanielC.
  • Navarrón, Carmen M.
  • Ballesteros-Esteban, Luis
  • Reig-Viader, R.
  • Morales, Aixa V.
  • Fernández-Lamo, Iván
  • Gómez-Domínguez, Daniel
  • Sato, Masaaki
  • Hayashi, Yasunori
  • Bayés, Àlex
  • Barco, Ángel
  • López-Atalaya, José P.
  • Menéndez de la Prida, Liset
Hippocampal sclerosis, the major neuropathological hallmark of temporal lobe epilepsy, is characterized by different patterns of neuronal loss. The mechanisms of cell-type-specific vulnerability and their progression and histopathological classification remain controversial. Using single-cell electrophysiology in vivo and immediate-early gene expression, we reveal that superficial CA1 pyramidal neurons are overactive in epileptic rodents. Bulk tissue and single-nucleus expression profiling disclose sublayer-specific transcriptomic signatures and robust microglial pro-inflammatory responses. Transcripts regulating neuronal processes such as voltage channels, synaptic signaling, and cell adhesion are deregulated differently by epilepsy across sublayers, whereas neurodegenerative signatures primarily involve superficial cells. Pseudotime analysis of gene expression in single nuclei and in situ validation reveal separated trajectories from health to epilepsy across cell types and identify a subset of superficial cells undergoing a later stage in neurodegeneration. Our findings indicate that sublayer- and cell-type-specific changes associated with selective CA1 neuronal damage contribute to progression of hippocampal sclerosis., This work was supported by grants from MICINN (RTI2018-098581-B-I00 to L.M.P.), Fundación Tatiana Pérez de Guzman el Bueno, and the SynCogDis Network (SAF2014-52624-REDT and SAF2017- 90664-REDT to L.M.P. and A. Bayes). Collaboration between L.M.d.l.P. and Y.H. was supported by Human Frontiers Science Program (HFSP) grant RGP0022/2013. J.P.L.-A. was supported by grants from MICIU co-financed by ERDF (RYC-2015-18056 and RTI2018-102260-B-I00) and Severo Ochoa grant SEV-2017-0723. R.R.-V. and A. Bayes were supported by MINECO BFU2015-69717-P and RTI2018-097037-B-100 and a Marie Curie career integration grant (ref. 304111). A.V.M. was supported by MICINN (SAF2017- 85717-R) and Fundación Alicia Koplowitz. A. Barco was supported by grants SAF2017-87928-R from MICINN co-financed by ERDF and RGP0039/2017 from the Human Frontiers Science Program Organization. The Instituto de Neurociencias is a ‘‘Centre of Excellence Severo Ochoa.’’ D.G.-D. and C.M.N. hold PhD fellowships from MICINN (BES-2013-064171 and BES2016-076281, respectively)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Transcriptional regulatory dynamics underlying neuroinflammation-associated states of microglia

  • Navarrón, Carmen M.
Programa de Doctorado en Neurociencias por la Universidad Miguel Hernández de Elche (IN-CSIC)., [EN] Microglia heterogeneity has been shown in both healthy and chronic neurodegenerative conditions, however, very little is known about microglia chromatin accessibility and transcriptome landscape during acute neuroinflammation. We combined bulk RNAsequencing and ATAC-sequencing on FACS-sorted microglia population with single molecule in situ hybridization (RNAscope), to reveal dynamic transitions across microglia functional states along the acute neuroinflammatory response. We identify an immediateearly cytokine-related (Il1b) and an immediate-sustained interferon response (Oasl2) microglia; a delayed response associated to heterogeneous proliferative microglia (Ms4a4a); and a delayed-sustained late stage of MHC-II-expressing (Axl) microglia; altogether with a transient loss of homeostatic genes (P2ry12, Cx3cr1 among others). Meta-analysis of published DAM microglia marker genes and LPS-responsive microglia shows that late stage of acute inflammation-associated microglia shares DAM phenotype. We confirm the presence of DAM and IRM microglia by microglia single-cell RNA-sequencing of J20 mouse model of AD. Moreover, we identify in situ by RNAscope of common acute and chronic neuroinflammation marker genes, a specific upregulation of the interferon-related marker (Oasl2) in the proximity of diffuse Aβ plaques whereas the phagocytic-related marker (Axl) is expressed by microglia in the surrounding of both dense and diffuse Aβ plaques. We also revealed an increase in the expression of both Oasl2 and Axl in human postmortem brain tissue from AD patients. Finally, in silico transcription factor motif analysis shows the RelA/p65 subunit of the transcription factor NF-κB as a key regulator of microglia cytokine-related transcriptional program. Conditional depletion of RelA in microglia during adulthood (RelA-cKO mice) recapitulates the interferon-related (with upregulation of Oas family) and phagocytic microglia phenotypes (with an upregulation of Axl) that is sufficient to alter instrumental learning and memory, and LTP. Our findings reveal common microglia signatures in acute (LPS) and chronic (AD) inflammatory conditions both in mouse animal models and human AD. Depletion of RelA reprograms microglia towards a phenotype present in both the late state in acute LPS, and Aβ plaques-associated microglia in chronic disease. Our work deepens our knowledge of microglia heterogeneity in acute and chronic neuroinflammatory response, with major implications for our understanding of microglia contributions to disease., [ES] La heterogeneidad de la microglía ha sido demostrada tanto en el cerebro sano comoen condiciones patológicas. Sin embargo, los cambios en la accesibilidad de la cromatina y el perfil transcripcional de la microglía durante una inflamación aguda son poco conocidos. La combinación de RNA-sequencing y ATAC-sequencing en microglía aislada por FACS junto con ensayos de hibridación in situ (RNAscope), muestran que la microglía lleva a cabo transiciones dinámicas entre distintos estados funcionales a lo largo de la respuesta inflamatoria aguda. Hemos identificado una respuesta temprana-corta compuesta por genes relacionados con la respuesta de las citoquinas (Il1b) y una respuesta tempranasostenida compuesta por genes de la vía del interferón (Oasl2); una respuesta tardía y heterogénea asociada la función proliferativa de la microglía (Ms4a4a); y una respuesta tardía-sostenida relacionada con la expresión de MHC-II (Axl); al mismo tiempo, hay una disminución transitoria en la expresión de genes homeostáticos (P2ry12, Cx3cr1, entre otros). Tras meta-analizar datos publicados de marcadores de DAM microglía junto con los genes identificados en nuestro estudio con LPS, observamos que los marcadores que identifican a la microglía DAM son compartidos con los expresados por la microglía en los estadios tardíos de inflamación aguda. Confirmamos la presencia de DAM e IRM microglía en el modelo de AD J20 mediante single-cell RNA-sequencing de microglía aislada. Además, identificamos mediante RNAscope de marcadores comunes de neuroinflamación aguda y crónica un aumento en la expresión de Oasl2 en la proximidad de las placas β-amiloideas difusas, mientras que el aumento observado en la expresión de Axl ocurre tanto en placas β-amiloideas difusas como compactas. También mostramos un aumento en la expresión de Oasl2 y Axl en tejido post-mortem de pacientes con enfermedad de Alzheimer. Finalmente, hemos identificado, mediante un análisis in silico de motivos de unión de factores de transcripción, a la subunidad RelA/p65 del factor de transcripción NFκB como un regulador clave en la microglía del programa transcripcional relacionado con la expresión de citoquinas. La depleción condicional de RelA en la microglía durante la etapa adulta recapitula la respuesta relacionada con el interferón (con un aumento en la expresión de la familia Oas) y la fagocitosis (con un aumento en la expresión de Axl) que es suficiente para alterar el aprendizaje instrumental y la LTP. Nuestros hallazgos muestran estados comunes de la microglía en condiciones inflamatorias agudas (LPS) y crónicas (AD) tanto en modelos animales como en humano. La depleción selectiva de RelA reprograma a la microglía hacia un fenotipo presente tanto en los estados tardíos en la respuesta aguda a LPS como en enfermedad crónica. Nuestro trabajo aumenta el conocimiento actual sobre la heterogeneidad de la microglía en situaciones neuroinflamatorias agudas y crónicas lo que supone grandes implicaciones para nuestro entendimiento sobre cómo el papel que juega la microglía en diferentes patologías del CNS., The present PhD thesis has been funded by the following research agencies: Dña. Carmen María Navarrón Izquierdo is recipient of a FPI contract (BES-2016-076281) associated with the excellence program Severo Ochoa (SEV-2013-0317). The present PhD thesis has been supported by the grants SAF2014-60233-JIN RYC-2015-18056, and RTI2018-102260-BI00, from MICINN co-financed by the European Regional Development Fund (ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A protocol to extract cell-type-specific signatures from differentially expressed genes in bulk-tissue RNA-seq

  • Marquez-Galera, Angel
  • Menéndez de la Prida, Liset
  • López-Atalaya, José P.
Bulk-tissue RNA-seq is widely used to dissect variation in gene expression levels across tissues and under different experimental conditions. Here, we introduce a protocol that leverages existing single-cell expression data to deconvolve patterns of cell-type-specific gene expression in differentially expressed gene lists from highly heterogeneous tissue. We apply this protocol to interrogate cell-type-specific gene expression and variation in cell type composition between the distinct sublayers of the hippocampal CA1 region of the brain in a rodent model of epilepsy. For complete details on the use and execution of this protocol, please refer to Cid et al. (2021)., This work was supported by grants from MICINN (RTI2018-098581-B-I00 to L.M.P.), Fundación Tatiana Pérez de Guzman el Bueno to L.M.P., and the SynCogDis Network (SAF2014-52624-REDT and SAF2017-90664-REDT to L.M.P.). J.P.L.-A. was supported by grants from MICIU co-financed by ERDF (RYC-2015-18056 and RTI2018-102260-B-I00) and Severo Ochoa grant SEV-2017-0723. The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Secondary loss of miR-3607 reduced cortical progenitor amplification during rodent evolution

  • Chinnappa, Kaviya
  • Cárdenas, Adrián
  • Prieto-Colomina, Anna
  • Villalba Requena, Ana
  • Marquez-Galera, Angel
  • Soler, Rafael
  • Nomura, Yuki
  • Llorens-Álvarez, Esther
  • Tomasello, Ugo
  • López-Atalaya, José P.
  • Borrell, Víctor
The evolutionary expansion and folding of the mammalian cerebral cortex resulted from amplification of progenitor cells during embryonic development. This process was reversed in the rodent lineage after splitting from primates, leading to smaller and smooth brains. Genetic mechanisms underlying this secondary loss in rodent evolution remain unknown. We show that microRNA miR-3607 is expressed embryonically in the large cortex of primates and ferret, distant from the primate-rodent lineage, but not in mouse. Experimental expression of miR-3607 in embryonic mouse cortex led to increased Wnt/β-catenin signaling, amplification of radial glia cells (RGCs), and expansion of the ventricular zone (VZ), via blocking the β-catenin inhibitor APC (adenomatous polyposis coli). Accordingly, loss of endogenous miR-3607 in ferret reduced RGC proliferation, while overexpression in human cerebral organoids promoted VZ expansion. Our results identify a gene selected for secondary loss during mammalian evolution to limit RGC amplification and, potentially, cortex size in rodents., This work was supported by Santiago Grisolía predoctoral fellowship (K.C.), Generalitat Valenciana I+D+i programs grant APOSTD/2019/059 (A.C.), Fundación Tatiana Pérez de Guzmán el Bueno predoctoral fellowship (A.P.-C.), Agencia Estatal de Investigación SVP-2014-068671 (A.V.), Spanish State Research Agency FPI contract (R.S.), Spanish State Research Agency grant RYC-2015-18056 (J.P.L.-A.), Spanish State Research Agency grant RTI2018-102260-B-100 (J.P.L.-A.), Spanish State Research Agency grant SAF2015-69168-R (V.B.), Spanish State Research Agency grant PGC2018-102172-B-I00 (V.B.), Spanish State Research Agency “Severo Ochoa” Programme for Centers of Excellence in R&D grant SEV-2017-0723 (V.B.), and European Research Council grant 309633 (V.B.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transcriptional regulation of chemokine network by biologic monotherapy in ileum of patients with Crohn's disease

  • Linares, Raquel
  • Gutiérrez, Ana
  • Marquez-Galera, Angel
  • Caparrós, Esther
  • Aparicio, José R.
  • Madero, Lucía
  • Payá, Artemio
  • López-Atalaya, José P.
  • Francés, Rubén
[Background]: Crohn’s disease (CD) exacerbation is marked by an intense cellular trafficking. We set out to determine the specific impact of biologic therapies on regulating chemokine network gene expression in healthy, mildly and severely inflamed tissue of CD patients., [Methods]: Twenty CD patients on biologics (adalimumab, ustekinumab, vedolizumab) or untreated undergoing colonoscopy due to clinical symptoms of flare. Healthy, mildly and severely inflamed ileum biopsies from each patient were collected. Chemokines and receptors gene expression was analyzed and a STRING analysis for functional enrichment was performed., [Results]: The chemokine network exhibited wide transcriptional differences among tissues in active untreated patients, whereas all biologic treatments reduced these differences and homogenized their transcriptional activity. In mildly inflamed tissue, all treatments showed gene upregulation while ustekinumab additionally maintained the downregulation of genes such as CCL2, CCL3, CCL17 or CCL23, involved in T cell chemotaxis, inflammatory monocyte and NK trafficking. In severely inflamed tissue, all treatments shared a downregulatory effect on chemokines controlling T cell response (i.e. CXCL16, CXCR3). Adalimumab and vedolizumab significantly reduced the expression of genes promoting antigen presentation by DCs and the initiation of leukocyte extravasation (i.e. CXCL12, CCL25, CCR7). Ustekinumab significantly reduced genes positively regulating Th1 cytokine production and IL-8 mediated signaling (i.e. IL1B, XCL1, CXCR1, CXCR2)., [Conclusion]: Biologic therapies differentially target the chemokine network gene expression profile in the ileal tissue of active CD patients. These results may contribute to better understanding cell homing and to defining future personalized therapeutic strategies for CD patients., This study was partially funded by grants from Asociación Española de Gastroenterología (AEG), Madrid, Spain, to R.F.; from Instituto de Salud Carlos III (PI21/01702), Madrid, Spain., to A.G.; from the Spanish State Research Agency (AEI), cofinanced by ERDF (RYC-2015-18056 and RTI2018-102260-B-I00) to J.P.L.-A. The Instituto de Neurociencias (UMH-CSIC) is a “Centre of Excellence Severo Ochoa” (SEV-2017-0723)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CBP and p300 jointly maintain neural progenitor viability but play unique roles in the differentiation of neural lineages

  • González-Martínez, Rocio
  • Marquez-Galera, Angel
  • Blanco, Beatriz del
  • López-Atalaya, José P.
  • Barco, Ángel
  • Herrera, Eloisa
This article belongs to the Special Issue Neural Stem Cells: Developmental Mechanisms and Disease Modelling., The paralogous lysine acetyltransferases 3 (KAT3), CBP and P300, play critical roles during neurodevelopment, but their specific roles in neural precursors maintenance and differentiation remain obscure. In fact, it is still unclear whether these proteins are individually or jointly essential in processes such as proliferation of neural precursors, differentiation to specific neural cell types, or both. Here, we use subventricular zone-derived neurospheres as a potential ex vivo developmental model to analyze the proliferation and differentiation of neural stem cells (NSCs) lacking CBP, p300, or both proteins. The results showed that CBP and p300 are not individually essential for maintenance and proliferation of NSCs, although their combined ablation seriously compromised cell division. In turn, the absence of either of the two proteins compromised the differentiation of NSC into the neuronal and astrocytic lineages. Single-nucleus RNA sequencing analysis of neural cell cultures derived from CBP or p300 mutant neurospheres revealed divergent trajectories of neural differentiation upon CBP or p300 ablation, confirming unique functions and nonredundant roles in neural development. These findings contribute to a better understanding of the shared and individual roles of KAT3 proteins in neural differentiation and the etiology of neurodevelopmental disorders caused by their deficiency., R.G.-M. was the recipient of a Severo Ochoa fellowship from SEV-2017-0723. E.H.’s research is supported by grants from the National Grant Research Program (PID2019-110535GB-I00), Generalitat Valenciana (PROMETEO/2020/007), and Fundación La Caixa (HR21-00824). A.B.’s research is supported by grants from Fundación Tatiana Pérez de Guzmán el Bueno and Fundació la Marató de TV3, PCIN-2015-192-C02-01 and PID2020-118169RB-100 from MICINN co-financed by ERDF, PROMETEO/2020/007 from the Generalitat Valenciana, and RGP0039/2017 from the Human Frontiers Science Program Organization (HFSPO). J.L.A.’s research is funded by grants from MICIU co-financed by ERDF (RTI2018-102260-B-I00), and Generalitat Valenciana (PROMETEO/2020/007). The Instituto de Neurociencias is a “Center of Excellence Severo Ochoa” (SEV-2017-0723)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CBP is required for establishing adaptive gene programs in the adult mouse brain

  • Lipinski, Michal
  • Niñerola, Sergio
  • Fuentes-Ramos, Miguel
  • Valor, Luis Miguel
  • Blanco, Beatriz del
  • López-Atalaya, José P.
  • Barco, Ángel
Environmental factors and life experiences impinge on brain circuits triggering adaptive changes. Epigenetic regulators contribute to this neuroadaptation by enhancing or suppressing specific gene programs. The paralogous transcriptional coactivators and lysine acetyltransferases CREB binding protein (CBP) and p300 are involved in brain plasticity and stimulus-dependent transcription, but their specific roles in neuroadaptation are not fully understood. Here we investigated the impact of eliminating either CBP or p300 in excitatory neurons of the adult forebrain of mice from both sexes using inducible and cell type-restricted knock-out strains. The elimination of CBP, but not p300, reduced the expression and chromatin acetylation of plasticity genes, dampened activity-driven transcription, and caused memory deficits. The defects became more prominent in elderly mice and in paradigms that involved enduring changes in transcription, such as kindling and environmental enrichment, in which CBP loss interfered with the establishment of activity-induced transcriptional and epigenetic changes in response to stimulus or experience. These findings further strengthen the link between CBP deficiency in excitatory neurons and etiopathology in the nervous system., M.L. was the recipient of a Santiago Grisolia fellowship from Generalitat Valenciana. S.N. is the recipient of an FPI Pre-Doctoral Fellowship from the Spanish Ministry of Science and Innovation (MICINN). M.F.-R. is the recipient of an FPU-PhD Fellowship from the Spanish Ministry of Education. L.M.V. is the recipient of Miguel Servet II Contract CPII20/00025 from Instituto de Salud Carlos III (ISCIII) and the European Social Fund. A.B. research is supported by Grant 202003 from Fundación Tatiana Pérez de Guzmán el Bueno and Fundació la Marató de TV3; Grant PID2020-118169RB-100 from the Ministry of Science and Innovation cofinanced by the European Regional Development Fund (ERDF); Grant PROMETEO/2020/007 from the Generalitat Valenciana; and Grant RGP0039/2017 from the Human Frontiers Science Program Organization. L.M.V. research is supported by Grant PI19/00125 from Instituto de Salud Carlos III and the ERDF. J.P.L.-A. research is funded by grants from MICIU cofinanced by ERDF (Grant RTI2018-102260-B-I00), and Generalitat Valenciana (Grant PROMETEO/2020/007). The Instituto de Neurociencias is funded by “Centre of Excellence Severo Ochoa” Grant SEV-2017-0723., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cell-specific vulnerability to metabolic failure: the crucial role of parvalbumin expressing neurons in creatine transporter deficiency

  • Ghirardini, Elsa
  • Sagona, Giulia
  • Marquez-Galera, Angel
  • Calugi, Francesco
  • Navarrón, Carmen M.
  • Cacciante, Francesco
  • Chen, Siwei
  • Di Vetta, Federica
  • Dadà, Lorenzo
  • Mazziotti, Raffaele
  • Lupori, Leonardo
  • Putignano, Elena
  • Baldi, Pierre
  • López-Atalaya, José P.
  • Pizzorusso, Tommaso
  • Baroncelli, Laura
Mutations in the solute carrier family 6-member 8 (Slc6a8) gene, encoding the protein responsible for cellular creatine (Cr) uptake, cause Creatine Transporter Deficiency (CTD), an X-linked neurometabolic disorder presenting with intellectual disability, autistic-like features, and epilepsy. The pathological determinants of CTD are still poorly understood, hindering the development of therapies. In this study, we generated an extensive transcriptomic profile of CTD showing that Cr deficiency causes perturbations of gene expression in excitatory neurons, inhibitory cells, and oligodendrocytes which result in remodeling of circuit excitability and synaptic wiring. We also identified specific alterations of parvalbumin-expressing (PV+) interneurons, exhibiting a reduction in cellular and synaptic density, and a hypofunctional electrophysiological phenotype. Mice lacking Slc6a8 only in PV+ interneurons recapitulated numerous CTD features, including cognitive deterioration, impaired cortical processing and hyperexcitability of brain circuits, demonstrating that Cr deficit in PV+ interneurons is sufficient to determine the neurological phenotype of CTD. Moreover, a pharmacological treatment targeted to restore the efficiency of PV+ synapses significantly improved cortical activity in Slc6a8 knock-out animals. Altogether, these data demonstrate that Slc6a8 is critical for the normal function of PV+ interneurons and that impairment of these cells is central in the disease pathogenesis, suggesting a novel therapeutic venue for CTD., This work has been supported by grant GR-2017–02364378 funded by the Italian Ministry of Health and by Telethon grant GGP19177 to LB; Italian Ministry of Health, RC 2021; grant from Fondazione Cassa di Risparmio di Firenze “Human Brain Optical Mapping” to TP; grants from the Spanish Ministry of Science and Innovation (MICINN) co-financed by ERDF (grant no. RTI2018-102260-B-I00; Generalitat Valenciana, project no. PROMETEO/2020/007; and CSIC Interdisciplinary Thematic Platform (PTI +) NEURO-AGINGl + (PTI-NEURO-AGING +). C.M.N-I. was the recipient of a FPI fellowship from the MICINN. The Instituto de Neurociencias (UMH-CSIC) is a “Centre of Excellence Severo Ochoa” (grant no. SEV-2017–0723)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations

  • Kass Youssef, Khalil
  • Narwade, Nitin
  • Arcas, Aída
  • Marquez-Galera, Angel
  • Jiménez-Castaño, Raúl
  • López-Blau, Cristina
  • Fazilaty, Hassan
  • García-Gutiérrez, David
  • Cano, Amparo
  • Galcerán, Joan
  • Moreno-Bueno, Gema
  • López-Atalaya, José P.
  • Nieto, M. Ángela
Epithelial-to-mesenchymal transition (EMT) triggers cell plasticity in embryonic development, adult injured tissues and cancer. Combining the analysis of EMT in cell lines, embryonic neural crest and mouse models of renal fibrosis and breast cancer, we find that there is not a cancer-specific EMT program. Instead, cancer cells dedifferentiate and bifurcate into two distinct and segregated cellular trajectories after activating either embryonic-like or adult-like EMTs to drive dissemination or inflammation, respectively. We show that SNAIL1 acts as a pioneer factor in both EMT trajectories, and PRRX1 drives the progression of the embryonic-like invasive trajectory. We also find that the two trajectories are plastic and interdependent, as the abrogation of the EMT invasive trajectory by deleting Prrx1 not only prevents metastasis but also enhances inflammation, increasing the recruitment of antitumor macrophages. Our data unveil an additional role for EMT in orchestrating intratumor heterogeneity, driving the distribution of functions associated with either inflammation or metastatic dissemination., This work was supported by grants MICIU RTI2018-096501-B-I00 and MCI PID2021-125682NB-I00 to M.A.N., RTI2018-102260-B-I00 to J.P.L.-A. and PID2022-136854OB-I00 to G.M.-B., all funded by MICIU/AEI/10.13039/501100011033 and by FEDER; UE Funds were also provided by the AECC Scientific Foundation (FC_AECC PROYE19073NIE to M.A.N. and PROYE19036MOR to G.M.-B.), Instituto de Salud Carlos III (CIBERONC, CB16/12/00295 to G.M.-B. and A.C.; CIBERER, CB19/07/00038 to M.A.N.), Generalitat Valenciana (Prometeo 2021/45) and the European Research Council (ERC AdG 322694) to M.A.N., who also acknowledges financial support from Centro de Excelencia Severo Ochoa, grant CEX2021-001165-S, funded by MCIN/AEI/10.13039/501100011033, and support from the Scientific Network Conexión Cáncer funded by CSIC, Spain. K.K.Y. was a holder of an EMBO Long-Term fellowship and a ‘Severo Ochoa Excellence Program’ Postdoctoral contract and currently holds an investigator contract from the AECC Scientific Foundation (Ayudas AECC investigador 2022). N.N. held a contract associated with NEUcrest European Union’s Horizon 2020 Research and Innovation Program under Marie Skłodowska-Curie (grant agreement 860635, ITN NEUcrest to M.A.N.). R.J.-C. holds a ‘Severo Ochoa Excellence Programme’ PhD contract (PRE2020-091888)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed, Modelo experimental animal, Modelo experimental alternativo-NAM, Mamíferos - Roedores, in silico, in vitro - Sistemas de cultivo - Cultivos 2D - Cultivo 2D sin fluídica, in vitro - Sistemas de cultivo - Cultivos 3D, ex vivo
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Type I interferon signalling and interferon-responsive microglia in health and disease

  • López-Atalaya, José P.
  • Bhojwani-Cabrera, Aysha M.
Recent evidence suggests that type I interferon (IFN-I) signalling extends beyond its canonical roles in antiviral defence and immunomodulation. Over the past decade, dysregulated IFN-I signalling has been linked to genetic disorders and neurodegenerative diseases, where it may contribute to neurological impairments. Microglia have emerged as key mediators of IFN-I responses in the central nervous system. A distinct transcriptional state responsive to interferons has recently been identified in microglia. The activation of the IFN-I pathway in these cells is now recognised as pivotal in both development and neurodegeneration. This review is divided into two main sections: the first examines the broader role of IFN-I signalling in the central nervous system, particularly its contribution to neurological dysfunction; the second focuses on the specific state of interferon-responsive microglia, exploring its mechanisms and relevance in neurodegenerative conditions. Finally, we discuss how these areas intersect and their implications for both healthy and diseased states., We thank Angel Marquez-Galera for his help in the preparation of Fig. 4. Graphical abstract and Figure 1 were created with BioRender.com. We thank Lopez-Atalaya's laboratory members for helpful discussions and suggestions on the early version of the manuscript. This work was supported by grants RTI2018-102260-B-I00 funded by MCIU/AEI/10.13039/501100011033 and by ERDF A way of making Europe; PROMETEO/2020/007 funded by Generalitat Valenciana. AMBC holds FPI fellowship PRE2019-090492 funded by MCIU/AEI/10.13039/501100011033 and ESF Investing in your future. JPLA acknowledges financial support from Centro de Excelencia Severo Ochoa Grant CEX2021-001165-S funded by MCIU/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multiscale Approximations to Understand the Complex Role of Microglia in Alzheimer's Disease

  • Martínez-Tazo, Patricia
  • Mejías-Ortega, Marina
  • López-López, Verónica
  • Bhojwani-Cabrera, Aysha M.
  • Saxton, Emma
  • Canals, Santiago
  • Hardingham, Giles E.
  • Gutiérrez, Antonia
  • López-Atalaya, José P.
  • De Santis, Silvia
Microglia, the resident innate immune cells of the central nervous system, play a pivotal role in the pathogenesis of Alzheimer's disease (AD). Microglia are now recognized as a highly dynamic and heterogeneous population whose molecular and functional states vary with spatial context, disease stage, and genetic background. Recent discoveries across multiple scales from genetics, molecular and cellular biology, to systems-level imaging and epidemiology have underscored the complex and context-dependent contributions of microglia to the AD cascade. Together, these findings highlight the need for integrative, multiscale approaches that bridge molecular, cellular, and systemic perspectives to elucidate the diverse roles of microglia and their impact on disease progression. This mini-review discusses recent advances in understanding microglial biology across these dimensions and outlines current challenges toward achieving a more unified and therapeutically oriented framework for studying microglia in AD., This work was supported by the Instituto de Salud Carlos III (PI24/00274), the Generalitat Valenciana (PROMETEO 2020/007, CIESGT/2025/06, CIPROM/2022/15, CIDEGENT/2021/015), the Ministerio de Ciencia e Innovación (PID2021-129053OB-I00, PID2021-128909NA-I00, CNS2023-144883, RTI2018-102260-B-I00, PID2021-128158NB-C21, PID2024-162400OB-C21, PCI2024-153491), the Fundacion Pasqual Maragall (2023–1296), the UK Dementia Research Institute, the Program for Centres of Excellence in R&D Severo Ochoa (CEX2021-001165-S) the Junta de Andalucía (CTS950-G-FEDER), and PMT is supported by the Spanish Ministry through a PhD fellowship FPU20/05737., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sex-dependent interferon signaling contributes to female-biased vulnerability in Alzheimer’s disease

  • López-López, Verónica
  • Iniesta, Gerard
  • Galán-Ganga, Marcos
  • Expósito-Coca, Alejandro
  • Durán-Laforet, Violeta
  • Bhojwani-Cabrera, Aysha M.
  • Navarrón, Carmen M.
  • Guillot-Fernández, Marina
  • Venero, José L.
  • Sánchez-Mut, José V.
  • Barco, Ángel
  • Giralt, Albert
  • López-Atalaya, José P.
[Data availability] The transcriptomics data sets generated in this study can be accessed at the GEO public repository using the accession number GSE304521 and GSE304362. In addition, publicly available single-cell RNA-seq data (GSE173242) were also reanalyzed as part of this study [46]. Human RNA-seq data used in this study were obtained from the publicly available The Mount Sinai Brain Bank (MSBB) study, hosted on the AD Knowledge Portal (https://adknowledgeportal.org/). The dataset is accessible via Synapse (https://www.synapse.org/): syn3159438; metadata: syn29855570; count data: syn27068754). The results published here are in whole or in part based on data obtained from the AD Knowledge Portal (https://adknowledgeportal.org/). These data were generated from postmortem brain tissue collected through the Mount Sinai VA Medical Center Brain Bank and were provided by Dr. Eric Schadt from Mount Sinai School of Medicine. Processed data and code used for statistical analysis, gene expression processing, and Fig. generation are available upon request from the corresponding author., Alzheimer’s disease (AD) disproportionately affects women, yet the biological basis of this sex bias remains unclear. Here, we identify sex-dependent interferon signaling as a contributor to this disparity. Transcriptomic profiling of postmortem AD tissue and APP/PS1 mice revealed preferential enrichment of interferon-responsive gene programs in females. In APP/PS1 mice, heightened interferon responses were associated with increased neurodegenerative features, and single-cell transcriptomic analyses identified microglia as a major cellular compartment engaging interferon responses. To test causality, we manipulated interferon signaling in vivo. Acute systemic interferon activation promoted AD-like neuropathological alterations. Genetic amplification of interferon signaling in microglia exacerbated neuroinflammatory and neurodegenerative features in APP/PS1 mice, whereas pharmacological inhibition through cGAS-STING blockade suppressed interferon responses, reduced neuropathology, and preserved cognitive performance in female APP/PS1 mice. Together, these findings identify microglial interferon signaling as a modifiable contributor to AD-associated neuropathology and suggest a neuroimmune mechanism underlying the increased vulnerability of females to the disease., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. V.L-L. is the recipient of a 2021 neuroscience doctoral fellowship from the Fundación Tatiana Pérez de Guzmán el Bueno. G.I. holds a Formación de Personal Investigador (FPI) contract (CEX2021-001165-S-20–2), associated with “Severo Ochoa” grant CEX2021-001165-S from the MCIU/AEI/https://doi.org/10.13039/501100011033. M.G.-G received the support from “la Caixa” Foundation (ID 100010434), fellowship code is LCF/BQ/DR21/11880016. V.D-L holds a CIAPOS contract (CIAPOS/2024/131) funded by Generalitat Valenciana (GVA) and the European Social Fund Plus (ESF +). A.B-C. held a Formación de Personal Investigador (FPI) contract (PRE2019-090492), associated with grant RTI2018-102260-B-I00 awarded to J.P.L-A., and funded by MCIU/AEI/https://doi.org/10.13039/501100011033 and by “ERDF A way of making Europe”. M.G-F. is the recipient of a Formación de Profesorado Universitario contract (FPU22/01375) funded by the Spanish Ministry of Science, Innovation and Universities (MICIU). J.L.V research is supported by grant PID2024-157400OB-I00 funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and ERDF/EU. J.V.S.-M. research is supported by the Pasqual Maragall Foundation (PMRP/2022/1184), the MICIU/AEI/https://doi.org/10.13039/501100011033 and ERDF/EU (PID2022-143263OB-I00), and the Valencian Regional Government’s Prometeo Programme (PROMETEO/2021/045). A.B. research is supported by grants FCAIXA HR22-00394 from Fundación LaCaixa, PID2023-148442NB-I00 from AEI co-financed by ERDF, and CIPROM/2023/15 from the Generalitat Valenciana. A.G. research is supported by European Union NextGenerationEU/PRTR CNS2022—135391 (“Consolidación” program) and the Fundación Ramón Areces (CIVP21A7024). J.P.L-A. research is supported by MCIU/AEI/https://doi.org/10.13039/501100011033 and by ERDF, EU (PID2021-129053OB-I00; PID2024-163108OB-I00), and the Generalitat Valenciana, Conselleria d’Educació, Universitats i Ocupació (PROMETEO 2020/007; CIPROM/2023/15). The Institute of Neurosciences is a Severo Ochoa Center of Excellence (grant CEX2021-001165-S, funded by MCIU/AEI/https://doi.org/10.13039/501100011033)., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (CEX2021-001165-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders

  • Alvaro-Espinosa, Laura
  • Marquez-Galera, Angel
  • Priego, Neibla
  • García-Calvo, Virginia
  • Perea-García, Maria
  • Hernandez-Oliver, Carolina
  • Retana, Diana
  • Sanchez, Oliva
  • Pablos-Aragoneses, Ana de
  • García-Gómez, Pedro
  • Graña-Castro, Osvaldo
  • Lapuente-Santana, Óscar
  • Serrano-Ron, Laura
  • Al-Shahrour, Fatima
  • Cayuela López, Ana
  • Peset, Isabel
  • Megías, Diego
  • Ola, Mihaela
  • Varešlija, Damir
  • Young, Leonie S.
  • Martí-Mateos, Yolanda
  • Enríquez, Jose A.
  • Hernández-Encinas, Elena
  • Blanco-Aparicio, Carmen
  • Soengas, María S.
  • Bernhagen, Juergen
  • Antón-Fernández, Alejandro
  • Ávila, Jesús
  • Marchena, Miguel A.
  • Torres, Maximiliano
  • Castro Soubriet, Fernando de
  • Márquez-Ropero, Mar
  • Sierra, Amanda
  • López-Atalaya, José P.
  • Valiente, Manuel
  • RENACER Group
The upregulation of CD74, a chaperone involved in MHC-II antigen processing, has been mostly interpreted as indicative of antigen presentation in multiple brain disorders. However, CD74 expression has also been described in cancer cells across multiple tumor types and in the tumor microenvironment, notably in glioma. In this study, we found that the presence of CD74+ microglia/macrophages, which was induced by increased levels of interferon γ in brains affected by metastases, did not relate to its canonical pathway. Instead, the alternative function of CD74 as a cytokine receptor was pivotal. Proliferating cancer cells produced high levels of the ligand migration inhibitory factor (MIF) that bound the CD74 receptor and induced its translocation to the nucleus where it activated an NF-κB-dependent program that promoted metastatic progression. In patients, a CD74 signature was associated with more aggressive progression of brain metastatic disease, although it had no clinical correlation with the matched primary tumor. Interestingly, a pan-disease noncanonical and clinically relevant signature derived from the CD74+ myeloid population was identified that occurred in additional brain disorders, including Alzheimer's disease and multiple sclerosis. The brain-penetrant drug ibudilast, which prevents the binding of MIF to CD74, decreased brain metastasis in experimental models in vivo and in patient-derived organotypic cultures ex vivo in a primary tumor-agnostic manner. These findings suggest that MIF/CD74-induced reprogramming of myeloid cells in brain disorders is a vulnerability that could be exploited therapeutically against brain metastases and possibly other brain disorders., We thank all members of the Brain Metastasis Group for critical discussion of the manuscript; the CNIO Core Facilities for their excellent assistance; and Estefanía Sánchez-Jiménez (F. de Castro laboratory at Instituto Cajal-CSIC) and the staff at the Animal Facilities of the Instituto Cajal-CSIC for their extraordinary help with animals of the cuprizone demyelinating murine model of multiple sclerosis. Special thanks to patients and their families who donated valuable materials to RENACER and all site personnel, investigators, funders, and industry partners who supported the generation of the data within this study. Postmortem cortical brain tissue blocks from patients with multiple sclerosis and controls, as well as the associated clinical and neuropathologic data, were supplied by the Multiple Sclerosis & Parkinson’s Tissue Bank at Imperial College (London, United Kingdom), funded by the Multiple Sclerosis Society of Great Britain and Northern Ireland, registered charity 207495. We thank J. Massagué (MSKCC) for some of the BrM cell lines. This study was funded by La Marató (201906-30-31-32; M. Valiente), MICIU (SAF2017-89643-R, SAF2014-57243-R, and SAF2015-62547-ERC to M. Valiente; PID2022-143110OB-I00 and RED2024-153909-E to F. de Castro), H2020-FETOPEN (828972; M. Valiente), Bristol Myers Squibb MRA Young Investigator Award (498103; M. Valiente), Cancer Research Institute (Clinic and Laboratory Integration Program CRI Award 2018; 54545; M. Valiente), LAB AECC 2019 (LABAE19002VALI; M. Valiente), AECC Coordinados (PRYCO234528VALI; M. Valiente), ERC CoG (864759; M. Valiente), and ERANET-TRANSCAN-3 (TRANSCAN2021-203; M. Valiente) with funds from Instituto de Salud Carlos III/NextGenerationEU/PRTR (AC20/00114) and FC AECC (TRNSC213878VALI), CaixaResearch Health (HR23-00051; M. Valiente), MINECO-Ramón y Cajal (RYC-2013-13365; M. Valiente), MICIU/AEI/10.13039/501100011033 and ERDF (RTI2018-102260-B-I00; J.P. Lopez-Atalaya), Generalitat Valenciana (PROMETEO/2020/007; J.P. Lopez-Atalaya), Ramón Areces Foundation (CIVP20S10662 to E. Ortega-Paino/M.-J. Artiga; CIVP19S8163 to M. Valiente; and CIVP19A5917 to F. de Castro), Spanish Ministry of Science and Innovation Competitiveness MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” (RTI2018-099267-B-I00 and PID2022-136698OB-I00; A. Sierra), Basque Government grants (IT1473-22; A. Sierra), Alzheimer Association award (AARG-NTF-24-1304352; A. Sierra), Breast Cancer Ireland (18239A01; L.S. Young), Research Ireland (19/FFP/6443; L.S. Young, 20/FFP-P/8597; D. Varešlija, and 23/SPP/11783; L.S. Young, D. Varešlija), Breast Cancer Now (2021 July PCC1460; L.S. Young, D. Varešlija, 2019 Aug SF1310 with the generous support of Walk the Walk; D. Varešlija), MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/Plan de Recuperación Transformación y Resiliencia, PRTR (RTI2018-099357-B-I00, PID2021-1279880B, and TED2021-131611B-I00; J.A. Enríquez), CIBERFES (CB16/10/00282; J.A. Enríquez), Foundation Leducq (17CVD04; J.A. Enríquez), MCIN/AEI/10 PID2023-147213OB-I00 (M.S. Soengas), ERC-Advanced Grant 884699 (M.S. Soengas), La Caixa International PhD Program Fellowship-Marie Sklodowska-Curie (LCF/BQ/DI17/11620028; P. García-Gómez and LCF/BQ/DI19/11730044; A. de Pablos-Aragoneses), AECC postdoctoral fellowship (POSTD19016PRIE; N. Priego), MINECO-Severo Ochoa PhD Fellowship (BES-2017-081995; L. Alvaro-Espinosa), FPI-Severo Ochoa Fellowship PRE2018-083478 awarded by MICIU/AEI/10.13039/501100011033, and European Social Funds (FSE invierte en tu futuro; Y. Martí-Mateos). M. Valiente is an EMBO YIP member (4053). The CNIC is supported by the Instituto de Salud Carlos III, the Ministerio de Ciencia, Innovación y Universidades, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033). The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa” (CEX2021-001165-S funded by MCIU/AEI/10.13039/501100011033). CNIO is supported by the ISCIII, the Ministerio de Ciencia e Innovación, and is a Severo Ochoa Center of Excellence (SEV-2015-0510)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2020-001041-S), With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sublayer- and cell-type-specific neurodegenerative transcriptional trajectories in hippocampal sclerosis

  • Cid, Elena|||0000-0003-4852-595X
  • Marquez-Galera, A.|||0000-0001-8400-9640
  • Valero, Manuel|||0000-0001-7860-577X
  • Gal, B.|||0000-0001-5189-1147
  • Medeiros, D.C.|||0000-0003-0243-1309
  • Navarron, C.M.
  • Ballesteros-Esteban, L.
  • Reig-Viader, Rita|||0000-0002-6893-6177
  • Morales, Aixa V.|||0000-0001-6295-5142
  • Fernandez-Lamo, Iván
  • Gomez-Dominguez, D.|||0000-0001-8189-498X
  • Sato, M.
  • Hayashi, Yasunori|||0000-0002-7560-3004
  • Bayés, Àlex|||0000-0002-5265-6306
  • Barco, Ángel
  • Lopez-Atalaya, J.P.
  • Prida, Liset Menéndez de la|||0000-0002-0160-6472
Hippocampal sclerosis, the major neuropathological hallmark of temporal lobe epilepsy, is characterized by different patterns of neuronal loss. The mechanisms of cell-type-specific vulnerability and their progression and histopathological classification remain controversial. Using single-cell electrophysiology in vivo and immediate-early gene expression, we reveal that superficial CA1 pyramidal neurons are overactive in epileptic rodents. Bulk tissue and single-nucleus expression profiling disclose sublayer-specific transcriptomic signatures and robust microglial pro-inflammatory responses. Transcripts regulating neuronal processes such as voltage channels, synaptic signaling, and cell adhesion are deregulated differently by epilepsy across sublayers, whereas neurodegenerative signatures primarily involve superficial cells. Pseudotime analysis of gene expression in single nuclei and in situ validation reveal separated trajectories from health to epilepsy across cell types and identify a subset of superficial cells undergoing a later stage in neurodegeneration. Our findings indicate that sublayer- and cell-type-specific changes associated with selective CA1 neuronal damage contribute to progression of hippocampal sclerosis.